A new trading day began on Friday, with Insmed Inc (NASDAQ: INSM) stock price down -1.03% from the previous day of trading, before settling in for the closing price of $80.78. INSM’s price has ranged from $21.92 to $82.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 22.42% over the last five years. Meanwhile, its annual earnings per share averaged -0.33%. With a float of $174.26 million, this company’s outstanding shares have now reached $178.85 million.
The firm has a total of 912 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.39%, while institutional ownership is 106.81%. The most recent insider transaction that took place on Feb 06 ’25, was worth 2,674,150. In this transaction Chief Medical Officer of this company sold 33,055 shares at a rate of $80.90, taking the stock ownership to the 138,053 shares. Before that another transaction happened on Feb 07 ’25, when Company’s Chief Medical Officer sold 60 for $79.59, making the entire transaction worth $4,775. This insider now owns 137,993 shares in total.
Insmed Inc (INSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.40% during the next five years compared to -4.82% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Here are Insmed Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 41.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.16 in the next quarter and is forecasted to reach -4.51 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Analysing the last 5-days average volume posted by the [Insmed Inc, INSM], we can find that recorded value of 1.78 million was lower than the volume posted last year of 1.96 million. As of the previous 9 days, the stock’s Stochastic %D was 82.98%. Additionally, its Average True Range was 2.81.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 89.82%, which indicates a significant increase from 77.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.47% in the past 14 days, which was lower than the 38.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $73.34, while its 200-day Moving Average is $66.02. Now, the first resistance to watch is $81.21. This is followed by the second major resistance level at $82.46. The third major resistance level sits at $83.60. If the price goes on to break the first support level at $78.82, it is likely to go to the next support level at $77.68. Now, if the price goes above the second support level, the third support stands at $76.43.
Insmed Inc (NASDAQ: INSM) Key Stats
With a market capitalization of 14.30 billion, the company has a total of 178,903K Shares Outstanding. Currently, annual sales are 305,210 K while annual income is -749,570 K. The company’s previous quarter sales were 93,430 K while its latest quarter income was -220,520 K.
